Relay Therapeutics (RLAY)'s 30-day implied volatility (IV30) was 40.8% at the close on November 5, 2026, down from 47.2% the day before, against a 52-week range of 39.4% to 124.8%. Its 20-day historical volatility was 62.7%.
Data as of November 5, 2026.